Jack Lee is an emerging entrepreneur in London, an Advisory Services client at TechAlliance, and recently became one of eight recipients of this year’s joint Ontario Brain Institute (OBI) and Ontario Centres of Excellence (OCE) fellowship award.
Lee’s award includes $50,000 over one-year to support the commercialization of a discovery that will help diagnose and treat tremor disorders.
Lee is a member of the research team at the Movement Disorders Clinic at London Health Sciences Centre. The video below shows what this team has done to put their work on the short list of promising brain treatments in Ontario.
The drastic reduction in tremors seen in the video is the result of a new treatment developed over the past two years by Dr. Mandar Jog and Dr. Fariborz Rahimi from the Movement Disorders Centre. The system helps to identify tremors in the patient, who can then be treated with an injection of Botulinum Toxin, a muscle relaxant that curbs the tremors and restores function to the limb.
“We have never been able to successfully use Botulinum Toxin as a treatment before, because we couldn’t identify where the tremors were coming from,” Jack said, commenting on how the treatment is a potential game changer. “We can now identify precisely where to inject the drug, and help reduce the tremors by 70%.”
Following the completion of his Masters at Western University, Lee joined the team as a clinical research associate with a Graduate Enterprise scholarship from the Stiller Centre. He is working to bring this technology and the treatment to market.
His company, Movement Disorder Diagnostic Technologies, cofounded by Dr. Jog, will continue with further trials and Health Canada approvals.
There are many types of tremor disorders that affect millions of people world-wide. More than 41 million people are diagnosed with essential tremors, more than 8 million people live with Parkinson’s disease, and many other patients suffer tremors as a result of other conditions including Torticollis, Multiple Sclerosis and stroke.